Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin - a podcast by JAMA Network

Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.

Further episodes of Coronavirus (COVID-19) Q&A

Further podcasts by JAMA Network

Website of JAMA Network